drugset / Trial / NCT00290251

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

NCT00290251

RandomizedCrossoverDouble-blindTreatment

Summary

This study will evaluate whether the experimental drug ulipristal acetate can shrink uterine fibroids in pre-menopausal women.

Timeline

Start
2006-02
Primary completion
2009-07
Completion
2010-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ulipristal Acetate Unknown 10 mg Oral
Comparator Ulipristal Acetate Unknown 20 mg Oral

Indications